サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672068

精密医療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Precision Medicine Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 130 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
精密医療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の精密医療の市場規模は、2024年の794億5,000万米ドルから2033年には3,296億9,000万米ドルに成長し、2026年～2033年の予測期間中に17.13％の堅調なCAGRを示すと予測されます。

精密医療市場は、個々の患者に合わせた治療アプローチを可能にするゲノミクス、バイオテクノロジー、データ分析の進歩に牽引され、急速な成長を遂げています。ヘルスケアが個別化治療へとシフトする中、特に標的治療ががん治療に革命をもたらしている腫瘍学において、精密医療ソリューションへの需要が高まっています。遺伝子検査とバイオマーカー同定の統合により、ヘルスケア提供者は治療効果を最適化し、副作用を最小限に抑えるカスタマイズされた治療計画を策定できるようになっています。患者も提供者も、より効果的で個別化されたヘルスケアソリューションを求めているため、この動向は市場を前進させると予想されます。

技術とデータ管理における革新もまた、精密医療市場の将来を形成しています。人工知能と機械学習の台頭により、複雑なデータセットを分析する能力が強化され、患者の層別化と治療成績の向上につながっています。さらに、バイオインフォマティクスの進歩により、ゲノムデータの臨床への統合が促進され、ヘルスケア提供者が患者固有の遺伝子プロファイルや情報に基づいた意思決定を行えるようになっています。これらの技術が進化し続けるにつれて、市場は希少疾患や慢性疾患を含む様々な治療領域にわたる精密医療用途の多様化を目の当たりにすることになると思われます。

さらに、製薬企業やヘルスケア機関が個別化治療の可能性を認識していることから、精密医療市場は研究開発への投資増加の恩恵を受けると思われます。臨床試験を進め、精密医療戦略を成功させるためには、学術機関、業界利害関係者、規制機関の協力が不可欠です。情勢が進展するにつれ、患者の最適な転帰を実現するための集学的アプローチの重要性が強調され、標準的な治療経路に精密医療を統合する方向に焦点が移っていくと思われます。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をクライアントに提供するために綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクションです。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに分けています。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業を包括的に評価しています。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：実績データと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測しています。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 精密医療の産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 精密医療の世界市場分析：技術別

  • 技術別の概要
  • 技術別の実績・予測データ分析
  • バイオインフォマティクス
  • ビッグデータ分析
  • 創薬
  • 遺伝子シーケンス
  • コンパニオン診断
  • その他

第6章 精密医療の世界市場分析：用途別

  • 用途別の概要
  • 用途別の実績・予測データ分析
  • 中枢神経系
  • 免疫学
  • 腫瘍学
  • 呼吸器
  • その他

第7章 精密医療の世界市場分析：最終用途別

  • 最終用途別の概要
  • 最終用途別の実績・予測データ分析
  • 診断企業
  • 製薬企業
  • ヘルスケアIT企業
  • その他

第8章 精密医療の世界市場分析：シーケンス技術別

  • シーケンス技術別の概要
  • シーケンス技術別の実績・予測データ分析
  • 合成によるシーケンス
  • イオン半導体シーケンス
  • ライゲーションによるシーケンス
  • パイロシーケンス
  • 1分子リアルタイムシーケンス
  • チェーンターミネーションシーケンス
  • ナノポアシーケンス

第9章 精密医療の世界市場分析：製品別

  • 製品別の概要
  • 製品別の実績・予測データ分析
  • 消耗品
  • 機器
  • サービス

第10章 精密医療の世界市場分析：投与経路別

  • 投与経路別の概要
  • 投与経路別の実績・予測データ分析
  • 経口
  • 注射

第11章 精密医療の世界市場分析：薬剤別

  • 薬剤別の概要
  • 薬剤別の実績・予測データ分析
  • アレクチニブ
  • オシメルチニブ
  • メポリズマブ
  • アリピプラゾールラウロキシル
  • その他

第12章 精密医療の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第13章 精密医療企業の競合情勢

  • 精密医療市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品の上市
  • その他の開発

第14章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Eagle Genomics
  • Pfizer
  • Intomics
  • Roche
  • Teva Pharmaceutical
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Technology (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Drug Discovery Market Sales By Geography (USD MN)
  • Gene Sequencing Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Diagnostic Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Healthcare IT companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Sequencing Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • Ion Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Sequencing by Ligation Market Sales By Geography (USD MN)
  • Pyrosequencing Market Sales By Geography (USD MN)
  • Single Molecule Real Time Sequencing Market Sales By Geography (USD MN)
  • Chain Termination Sequencing Market Sales By Geography (USD MN)
  • Nanopore Sequencing Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Analysis By Drugs (USD MN)
  • Alectinib Market Sales By Geography (USD MN)
  • Osimertinib Market Sales By Geography (USD MN)
  • Mepolizumab Market Sales By Geography (USD MN)
  • Aripiprazole Lauroxil Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Precision Medicine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Precision Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Precision Medicine Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Sequencing Technology
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Drugs
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Technology (USD MN)
  • Bioinformatics Market Sales By Geography (USD MN)
  • Big Data Analytics Market Sales By Geography (USD MN)
  • Drug Discovery Market Sales By Geography (USD MN)
  • Gene Sequencing Market Sales By Geography (USD MN)
  • Companion Diagnostics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • CNS Market Sales By Geography (USD MN)
  • Immunology Market Sales By Geography (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Respiratory Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Diagnostic Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Healthcare IT companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Sequencing Technology (USD MN)
  • Sequencing by Synthesis Market Sales By Geography (USD MN)
  • Ion Semiconductor Sequencing Market Sales By Geography (USD MN)
  • Sequencing by Ligation Market Sales By Geography (USD MN)
  • Pyrosequencing Market Sales By Geography (USD MN)
  • Single Molecule Real Time Sequencing Market Sales By Geography (USD MN)
  • Chain Termination Sequencing Market Sales By Geography (USD MN)
  • Nanopore Sequencing Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Consumables Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Global Market Analysis By Drugs (USD MN)
  • Alectinib Market Sales By Geography (USD MN)
  • Osimertinib Market Sales By Geography (USD MN)
  • Mepolizumab Market Sales By Geography (USD MN)
  • Aripiprazole Lauroxil Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11214898

Global Precision Medicine Market size is anticipated to grow from USD 79.45 Billion in 2024 to USD 329.69 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 17.13% during the forecast period of 2026 to 2033.

The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

  • Bioinformatics
  • Big Data Analytics
  • Drug Discovery
  • Gene Sequencing
  • Companion Diagnostics
  • Others

By Application

  • CNS
  • Immunology
  • Oncology
  • Respiratory
  • Others

By End-Use

  • Diagnostic Companies
  • Pharmaceutical Companies
  • Healthcare IT companies
  • Others

By Sequencing Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By Product

  • Consumables
  • Instruments
  • Services

By Route of Administration

  • Oral
  • Injectable

By Drugs

  • Alectinib
  • Osimertinib
  • Mepolizumab
  • Aripiprazole Lauroxil
  • Others
  • COMPANIES PROFILED
  • Biocrates Life Sciences
  • Tepnel Pharma Services
  • Novartis
  • Qiagen
  • Quest Diagnostics
  • Menarini Silicon Biosystems
  • NanoString Technologies
  • Eagle Genomics
  • Pfizer
  • Intomics
  • Roche
  • Teva Pharmaceutical
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PRECISION MEDICINE INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Sequencing Technology
    • 3.7.5 Market Attractiveness Analysis By Product
    • 3.7.6 Market Attractiveness Analysis By Route of Administration
    • 3.7.7 Market Attractiveness Analysis By Drugs
    • 3.7.8 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY

  • 5.1. Overview By Technology
  • 5.2. Historical and Forecast Data Analysis By Technology
  • 5.3. Bioinformatics Historic and Forecast Sales By Regions
  • 5.4. Big Data Analytics Historic and Forecast Sales By Regions
  • 5.5. Drug Discovery Historic and Forecast Sales By Regions
  • 5.6. Gene Sequencing Historic and Forecast Sales By Regions
  • 5.7. Companion Diagnostics Historic and Forecast Sales By Regions
  • 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. CNS Historic and Forecast Sales By Regions
  • 6.4. Immunology Historic and Forecast Sales By Regions
  • 6.5. Oncology Historic and Forecast Sales By Regions
  • 6.6. Respiratory Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data Analysis By End-Use
  • 7.3. Diagnostic Companies Historic and Forecast Sales By Regions
  • 7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.5. Healthcare IT companies Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY SEQUENCING TECHNOLOGY

  • 8.1. Overview By Sequencing Technology
  • 8.2. Historical and Forecast Data Analysis By Sequencing Technology
  • 8.3. Sequencing by Synthesis Historic and Forecast Sales By Regions
  • 8.4. Ion Semiconductor Sequencing Historic and Forecast Sales By Regions
  • 8.5. Sequencing by Ligation Historic and Forecast Sales By Regions
  • 8.6. Pyrosequencing Historic and Forecast Sales By Regions
  • 8.7. Single Molecule Real Time Sequencing Historic and Forecast Sales By Regions
  • 8.8. Chain Termination Sequencing Historic and Forecast Sales By Regions
  • 8.9. Nanopore Sequencing Historic and Forecast Sales By Regions

9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY PRODUCT

  • 9.1. Overview By Product
  • 9.2. Historical and Forecast Data Analysis By Product
  • 9.3. Consumables Historic and Forecast Sales By Regions
  • 9.4. Instruments Historic and Forecast Sales By Regions
  • 9.5. Services Historic and Forecast Sales By Regions

10. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 10.1. Overview By Route of Administration
  • 10.2. Historical and Forecast Data Analysis By Route of Administration
  • 10.3. Oral Historic and Forecast Sales By Regions
  • 10.4. Injectable Historic and Forecast Sales By Regions

11. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY DRUGS

  • 11.1. Overview By Drugs
  • 11.2. Historical and Forecast Data Analysis By Drugs
  • 11.3. Alectinib Historic and Forecast Sales By Regions
  • 11.4. Osimertinib Historic and Forecast Sales By Regions
  • 11.5. Mepolizumab Historic and Forecast Sales By Regions
  • 11.6. Aripiprazole Lauroxil Historic and Forecast Sales By Regions
  • 11.7. Others Historic and Forecast Sales By Regions

12. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 12.1. Regional Outlook
  • 12.2. Introduction
  • 12.3. North America Sales Analysis
    • 12.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.3.2 North America By Segment Sales Analysis
    • 12.3.3 North America By Country Sales Analysis
    • 12.3.4 United States Sales Analysis
    • 12.3.5 Canada Sales Analysis
    • 12.3.6 Mexico Sales Analysis
  • 12.4. Europe Sales Analysis
    • 12.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.4.2 Europe By Segment Sales Analysis
    • 12.4.3 Europe By Country Sales Analysis
    • 12.4.4 United Kingdom Sales Analysis
    • 12.4.5 France Sales Analysis
    • 12.4.6 Germany Sales Analysis
    • 12.4.7 Italy Sales Analysis
    • 12.4.8 Russia Sales Analysis
    • 12.4.9 Rest Of Europe Sales Analysis
  • 12.5. Asia Pacific Sales Analysis
    • 12.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.5.2 Asia Pacific By Segment Sales Analysis
    • 12.5.3 Asia Pacific By Country Sales Analysis
    • 12.5.4 China Sales Analysis
    • 12.5.5 India Sales Analysis
    • 12.5.6 Japan Sales Analysis
    • 12.5.7 South Korea Sales Analysis
    • 12.5.8 Australia Sales Analysis
    • 12.5.9 South East Asia Sales Analysis
    • 12.5.10 Rest Of Asia Pacific Sales Analysis
  • 12.6. Latin America Sales Analysis
    • 12.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.6.2 Latin America By Segment Sales Analysis
    • 12.6.3 Latin America By Country Sales Analysis
    • 12.6.4 Brazil Sales Analysis
    • 12.6.5 Argentina Sales Analysis
    • 12.6.6 Peru Sales Analysis
    • 12.6.7 Chile Sales Analysis
    • 12.6.8 Rest of Latin America Sales Analysis
  • 12.7. Middle East & Africa Sales Analysis
    • 12.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 12.7.2 Middle East & Africa By Segment Sales Analysis
    • 12.7.3 Middle East & Africa By Country Sales Analysis
    • 12.7.4 Saudi Arabia Sales Analysis
    • 12.7.5 UAE Sales Analysis
    • 12.7.6 Israel Sales Analysis
    • 12.7.7 South Africa Sales Analysis
    • 12.7.8 Rest Of Middle East And Africa Sales Analysis

13. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES

  • 13.1. Precision Medicine Market Competition
  • 13.2. Partnership/Collaboration/Agreement
  • 13.3. Merger And Acquisitions
  • 13.4. New Product Launch
  • 13.5. Other Developments

14. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY

  • 14.1. Top Companies Market Share Analysis
  • 14.2. Market Concentration Rate
  • 14.3. Biocrates Life Sciences
    • 14.3.1 Company Overview
    • 14.3.2 Company Revenue
    • 14.3.3 Products
    • 14.3.4 Recent Developments
  • 14.4. Tepnel Pharma Services
    • 14.4.1 Company Overview
    • 14.4.2 Company Revenue
    • 14.4.3 Products
    • 14.4.4 Recent Developments
  • 14.5. Novartis
    • 14.5.1 Company Overview
    • 14.5.2 Company Revenue
    • 14.5.3 Products
    • 14.5.4 Recent Developments
  • 14.6. Qiagen
    • 14.6.1 Company Overview
    • 14.6.2 Company Revenue
    • 14.6.3 Products
    • 14.6.4 Recent Developments
  • 14.7. Quest Diagnostics
    • 14.7.1 Company Overview
    • 14.7.2 Company Revenue
    • 14.7.3 Products
    • 14.7.4 Recent Developments
  • 14.8. Menarini Silicon Biosystems
    • 14.8.1 Company Overview
    • 14.8.2 Company Revenue
    • 14.8.3 Products
    • 14.8.4 Recent Developments
  • 14.9. NanoString Technologies
    • 14.9.1 Company Overview
    • 14.9.2 Company Revenue
    • 14.9.3 Products
    • 14.9.4 Recent Developments
  • 14.10. Eagle Genomics
    • 14.10.1 Company Overview
    • 14.10.2 Company Revenue
    • 14.10.3 Products
    • 14.10.4 Recent Developments
  • 14.11. Pfizer
    • 14.11.1 Company Overview
    • 14.11.2 Company Revenue
    • 14.11.3 Products
    • 14.11.4 Recent Developments
  • 14.12. Intomics
    • 14.12.1 Company Overview
    • 14.12.2 Company Revenue
    • 14.12.3 Products
    • 14.12.4 Recent Developments
  • 14.13. Roche
    • 14.13.1 Company Overview
    • 14.13.2 Company Revenue
    • 14.13.3 Products
    • 14.13.4 Recent Developments
  • 14.14. Teva Pharmaceutical
    • 14.14.1 Company Overview
    • 14.14.2 Company Revenue
    • 14.14.3 Products
    • 14.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies